Some Zepbound patients face a tough choice: Switch medicine or stop weight loss treatment IndyStarThe U.S. needs a revolution to harness the potential of GLP-1s for weight loss statnews.comThe Patients Forced to Switch From Zepbound to Wegovy The Wall Street JournalNew studies signal Ozempic, other drugs may reduce dementia risk Fox NewsGLP-1s for obesity are priced less than the value they provide Leerink Partners
